These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2610092)
1. Endotoxin shock, kinin system and PAF-acether in the rat. Damas J; Remacle-Volon G; Adam A; Bourdon V Adv Exp Med Biol; 1989; 247B():547-52. PubMed ID: 2610092 [No Abstract] [Full Text] [Related]
2. Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Lagente V; Braquet P; Vargaftig BB Pharmacol Res Commun; 1986 Aug; 18 Suppl():197-200. PubMed ID: 3774845 [No Abstract] [Full Text] [Related]
3. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity. Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954 [TBL] [Abstract][Full Text] [Related]
4. Interference of the PAF-acether antagonist BN 52021 with endotoxin-induced hypotension in the guinea-pig. Adnot S; Lefort J; Braquet P; Vargaftig BB Prostaglandins; 1986 Dec; 32(6):791-802. PubMed ID: 3562865 [TBL] [Abstract][Full Text] [Related]
5. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021. Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870 [TBL] [Abstract][Full Text] [Related]
6. Platelet activating factor is one of the mediators involved in endotoxic shock in pigs. Mózes T; Heiligers JP; Tak CJ; Zijlstra FJ; Ben-Efraim S; Saxena PR; Bonta IL J Lipid Mediat; 1991 Nov; 4(3):309-25. PubMed ID: 1764577 [TBL] [Abstract][Full Text] [Related]
7. Effect of PAF-antagonists in endotoxin shock--ovine and rat experiments. Bahrami S; Redl H; Thurnher M; Vogl C; Paul E; Schiesser A; Schlag G Prog Clin Biol Res; 1989; 308():931-6. PubMed ID: 2780740 [No Abstract] [Full Text] [Related]
8. The relative role of PAF-acether and icosanoids in septic shock. Etienne A; Hecquet F; Soulard C; Touvay C; Clostre F; Braquet P Pharmacol Res Commun; 1986 Aug; 18 Suppl():71-9. PubMed ID: 3774851 [TBL] [Abstract][Full Text] [Related]
9. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists. Koltai M; Hosford D; Braquet P J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981 [No Abstract] [Full Text] [Related]
10. Myoelectric intestinal disturbances in Escherichia coli endotoxic shock in rats. Involvement of platelet-activating factor. Pons L; Droy-Lefaix MT; Braquet P; Buéno L Lipids; 1991 Dec; 26(12):1359-61. PubMed ID: 1819734 [TBL] [Abstract][Full Text] [Related]
11. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Wallace JL; Steel G; Whittle BJ; Lagente V; Vargaftig B Gastroenterology; 1987 Oct; 93(4):765-73. PubMed ID: 3305134 [TBL] [Abstract][Full Text] [Related]
12. Role of paf-acether in the mediation of pathophysiological responses to aggregated immunoglobulins. Studies with the platelet-activating factor receptor antagonist BN 52021. Fernandez-Gallardo S; Cano E; Braquet P; Sanchez Crespo M Int J Immunopharmacol; 1988; 10(4):353-60. PubMed ID: 3139574 [TBL] [Abstract][Full Text] [Related]
13. Influence of inhibitors of the eicosanoid metabolism, and of eicosanoids- and PAF-acether antagonists on mortality and some biochemical parameters of three shock models. Bahr T; Schaper U; Becker K; Lueddeckens G; Förster W; Scheuch DW; Grupe R Prog Clin Biol Res; 1989; 301():229-33. PubMed ID: 2798447 [No Abstract] [Full Text] [Related]
14. PAF-cytokine autocatalytic feed-back network in septic shock: involvement in acute renal failure. Koltai M; Pirotzky E; Braquet P Nephrol Dial Transplant; 1994; 9 Suppl 4():69-72. PubMed ID: 7800272 [No Abstract] [Full Text] [Related]
15. Evidence of a role for PAF-acether in the pathophysiology of the shock state. Sanchez Crespo M; Inarrea P; Nieto ML; Fernandez-Gallardo S Pharmacol Res Commun; 1986 Aug; 18 Suppl():181-96. PubMed ID: 3774844 [TBL] [Abstract][Full Text] [Related]
16. PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists. Lagente V; Fortes ZB; Garcia-Leme J; Vargaftig BB J Pharmacol Exp Ther; 1988 Oct; 247(1):254-61. PubMed ID: 3171975 [TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats. López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516 [TBL] [Abstract][Full Text] [Related]
18. Desensitization and antagonism of rat polymorphonuclear leukocytes stimulated with PAF acether. Bureau M; Joseph D; Vargaftig BB Prostaglandins; 1987 Jan; 33(1):37-50. PubMed ID: 3035615 [TBL] [Abstract][Full Text] [Related]
19. Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock. De Kimpe SJ; Thiemermann C; Vane JR Br J Pharmacol; 1995 Dec; 116(8):3191-8. PubMed ID: 8719795 [TBL] [Abstract][Full Text] [Related]
20. Effect of platelet-activating factor (PAF-acether) and its specific receptor antagonist, BN 52021, on interleukin 1 (IL1) release and synthesis by rat spleen adherent monocytes. Pignol B; Hénane S; Mencia-Huerta JM; Rola-Pleszczynski M; Braquet P Prostaglandins; 1987 Jun; 33(6):931-9. PubMed ID: 3313526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]